Predictors of response to anti-TNF- therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register
about
Advances in rheumatology: new targeted therapeuticsInvestigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatmentBenefit of early treatment in inflammatory polyarthritis patients with anti-cyclic citrullinated peptide antibodies versus those without antibodiesMicrobiota and chronic inflammatory arthritis: an interwoven linkPersonalized biological treatment for rheumatoid arthritis: a systematic review with a focus on clinical applicabilityRate of discontinuation and drug survival of biologic therapies in rheumatoid arthritis: a systematic review and meta-analysis of drug registries and health care databasesBiologic efficacy optimization--a step towards personalized medicinePredictive factors of response to biological disease modifying antirheumatic drugs: towards personalized medicine.Targeting Low Disease Activity in Elderly-Onset Rheumatoid Arthritis: Current and Future Roles of Biological Disease-Modifying Antirheumatic DrugsNew pharmacological strategies in rheumatic diseasesAssociation of the response to tumor necrosis factor antagonists with plasma type I interferon activity and interferon-beta/alpha ratios in rheumatoid arthritis patients: a post hoc analysis of a predominantly Hispanic cohortA Personalized Approach to Biological Therapy Using Prediction of Clinical Response Based on MRP8/14 Serum Complex Levels in Rheumatoid Arthritis PatientsCD6 and syntaxin binding protein 6 variants and response to tumor necrosis factor alpha inhibitors in Danish patients with rheumatoid arthritisThe gene expression profile in the synovium as a predictor of the clinical response to infliximab treatment in rheumatoid arthritisBiologics registers in RA: methodological aspects, current role and future applications.The Effect of Stopping Smoking on Disease Activity in Rheumatoid Arthritis (RA). Data from BARFOT, a Multicenter Study of Early RAThe use of continuous data versus binary data in MTC models: a case study in rheumatoid arthritisIncorporating data from various trial designs into a mixed treatment comparison model.Alcohol consumption is associated with lower self-reported disease activity and better health-related quality of life in female rheumatoid arthritis patients in Sweden: data from BARFOT, a multicenter study on early RAPower Doppler ultrasonographic assessment of the joint-draining lymph node complex in rheumatoid arthritis: a prospective, proof-of-concept study on treatment with tumor necrosis factor inhibitors.Increase in circulating Th17 cells during anti-TNF therapy is associated with ultrasonographic improvement of synovitis in rheumatoid arthritisComparative Effectiveness of Tocilizumab and TNF Inhibitors in Rheumatoid Arthritis Patients: Data from the Rheumatic Diseases Portuguese Register, Reuma.ptDiscordant inflammation and pain in early and established rheumatoid arthritis: Latent Class Analysis of Early Rheumatoid Arthritis Network and British Society for Rheumatology Biologics Register data.Disease activity level, remission and response in established rheumatoid arthritis: performance of various criteria sets in an observational cohort, treated with anti-TNF agentsAn eight-gene blood expression profile predicts the response to infliximab in rheumatoid arthritis.Associations of smoking and alcohol consumption with disease activity and functional status in rheumatoid arthritis.Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology Biologics Register.Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics RegisterGenetics of rheumatoid arthritis susceptibility, severity, and treatment response.Impact of patient and disease characteristics on therapeutic success during adalimumab treatment of patients with rheumatoid arthritis: data from a German noninterventional observational studyDrug retention rates and treatment discontinuation among anti-TNF-α agents in psoriatic arthritis and ankylosing spondylitis in clinical practice.Differential expression of NK receptors CD94 and NKG2A by T cells in rheumatoid arthritis patients in remission compared to active disease.Drug survival rates of tumor necrosis factor inhibitors in patients with rheumatoid arthritis and ankylosing spondylitis.Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis.A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registriesTreatment of rheumatoid arthritis with tumour necrosis factor inhibitorsClinical efficacy of abatacept compared to adalimumab and tocilizumab in rheumatoid arthritis patients with high disease activity.Pre-treatment whole blood gene expression is associated with 14-week response assessed by dynamic contrast enhanced magnetic resonance imaging in infliximab-treated rheumatoid arthritis patientsSmoking and rheumatoid arthritis.Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci.
P2860
Q21093257-7C80B3D7-C407-46D0-9DD0-B02FFD61E3B0Q24310184-6578DB49-F263-496B-999E-EFAF58FABC8AQ24627677-CF81A3B5-1CCE-46D7-87BD-0BCE30FC777CQ26739010-12D8B687-3100-4A08-965D-CC6AFF886F8EQ26771652-79DAC277-58AB-41B2-BF78-2CBBB2430A12Q26778600-60AE0C5B-C514-4457-BC07-A3050BDC7635Q26783657-D44D01EB-37DA-4ACD-A711-13BCDF6684BCQ27692641-460105A3-ECBF-4C20-9B1B-80EAACC6F45BQ28073436-F97D7ADB-2765-4B6B-ACEF-BD435C720B9AQ28073763-34595EB2-163D-4C0C-8205-E192A9C7F11AQ28271779-C8E73CDE-F382-4097-B049-46C72FA09B7DQ28551075-6902F200-EBE8-4354-A34C-2FD2FB16D4CDQ28728734-16FB44F7-1308-4858-8DAB-8704286D7187Q28751012-D9EF92A8-4E4F-4979-9F65-5D4058CE7407Q30234303-E3888439-A5E4-4002-9411-78DB86B6E3D4Q30575606-0C6A328F-F154-41FA-B690-80AF88A08D98Q30576366-75012DFC-DD6E-4337-851D-DB5EEDE763C9Q30594247-87343547-CAF3-4FD6-965D-19F2FA81C29AQ30656861-8BA5D635-8C40-44C4-A8D3-D510D4279354Q30825520-2CA4D501-2CC9-4B6F-809A-6DAA812C58FDQ30832987-D5205631-C371-4CA1-A2E4-E4D8B6A5D074Q30956564-E3E1017E-BFB2-4786-989E-163B0EF1800EQ31148620-763FC6E7-2D1D-4C12-B9EE-5EA62132C96CQ33434163-E2CA2824-6A62-458D-BBA0-3AC5BC5F8CB1Q33511764-13A32EE7-8C8D-4BE2-AD97-0937614F817DQ33596873-48EDDADF-94B7-4913-A49A-CEAFDC6C41D8Q33646340-D898A1B2-E461-456D-8433-AF696BF7BB2CQ33726924-7F8EB404-6B78-4FE3-A88D-E8F5A1E8F826Q33841329-05FB08DA-B9CA-4520-ADE0-7A84BE397FD5Q33984823-09A8E189-FB6D-4CEB-B70B-7A0958CB4ECEQ33993099-85722CA7-24F0-40E8-B726-D7D7606E62B8Q34079261-7B68FA96-0C9D-4439-8EA5-07A6D0197182Q34208252-F2D613D7-905E-4035-9E06-0E8A4D7139B4Q34216613-A13C1D5E-09B2-4718-8996-AFEA66D2D48BQ34216770-3E77E080-98DC-4CE8-90B9-0C0C6B194C40Q34588629-11742DBC-45B9-427B-A4A2-A73DF7BEF776Q34656204-83FA9AF7-3B0C-4994-8F9A-8C5C3FC0CD2DQ34688901-4240BED8-0EC8-4677-8386-DB52593A80B2Q34834289-0BFCC27C-7A75-46F8-8E39-89E07AB6BF9DQ34886162-A4A1EAA0-8D51-4F73-8D93-814D7873105D
P2860
Predictors of response to anti-TNF- therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register
description
article
@en
im Mai 2006 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2006
@uk
name
Predictors of response to anti ...... heumatology Biologics Register
@en
Predictors of response to anti ...... heumatology Biologics Register
@nl
type
label
Predictors of response to anti ...... heumatology Biologics Register
@en
Predictors of response to anti ...... heumatology Biologics Register
@nl
prefLabel
Predictors of response to anti ...... heumatology Biologics Register
@en
Predictors of response to anti ...... heumatology Biologics Register
@nl
P2093
P921
P356
P1433
P1476
Predictors of response to anti ...... heumatology Biologics Register
@en
P2093
A J Silman
British Society for Rheumatology Biologics Register
K D Watson
K L Hyrich
P304
P356
10.1093/RHEUMATOLOGY/KEL149
P577
2006-05-16T00:00:00Z